Aecima2019-05-19T21:20:56+02:00

NOTICIAS

FDA Allows Continued Sales of Textured Breast Implants

13/05/2019|Destacadas, Noticias|

The United States Food and Drug Administration (FDA) has announced that it will allow continued sales of textured breast implants, which regulators in other nations have banned or restricted because of concerns about a rare cancer, breast implant- associated anaplastic large cell lymphoma (BIA-ALCL).